Albendazole
Sold as Paranthil, Zentel, Bendex, Cipla-medpro albendazole, Albendazole cospharm, Nubend, Wormadole, Worma-worma
Methyl N-(6-propylsulfanyl-1H-benzimidazol-2-yl)carbamate
Drag to rotate. Structure from PubChem CID 2082.
Background
Registration
- Applicants
- 7
- Registrations
- 10
- Schedule source
- SAHPRA documentation
Applicants and registrations
| Applicant | Brands | Dosages | Registrations | Schedule | Leaflets |
|---|---|---|---|---|---|
| Viatris South Africa (Pty) Ltd | Paranthil | tablets, suspension | 290552, 290553 | Not determined | None |
| Glaxosmithkline South Africa (Pty) LimitedCertificate held by Glaxosmithkline South Africa (Pty) Ltd1 of 2 cancelled | Zentel | 20 mg/ml, 400 mg | 300354, Q0075 | S2 | PIPIL |
| Cipla Medpro (Pty) Ltd1 of 2 cancelled | Bendex, Cipla-medpro albendazole | 400 | 310472, 340072 | Not determined | None |
| Cospharm Investments (Pty) Ltd | Albendazole cospharm | 1 mg | 610846 | S2 | PIPIL |
| Pharmascript Pharmaceuticals LtdCancelled | Nubend | 400 | A380425 | Not determined | None |
| Dezzo Trading 392 (Pty) LtdCertificate held by Shanur Healthcare (Pty) Ltd, | Wormadole | 400mg | A380426 | Not determined | PIPIL |
| Resmed healthcare | Worma-worma | Not stated | U0079 | Not determined | None |
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Paranthil tablets EACH TABLET CONTAINS ALBENDAZOLE 200 mg | Tablets | 29055229/12/0552 | Registered | Not determined | None |
| Paranthil suspension EACH 5 ml SUSPENSION CONTAINS ALBENDAZOLE 100 mg | Suspension | 29055329/12/0553 | Registered | Not determined | None |
| Zentel 400 EACH TABLET CONTAINS ALBENDAZOLE 400 mg | 400 mgTablets | 30035430/12/0354Approved 26 April 2024 | Registered | S2 | PIPIL |
| Bendex-400 EACH TABLET CONTAINS ALBENDAZOLE 400,0 mg | 400 | 31047231/12/0472 | Registered | Not determined | None |
| Cipla-medpro albendazole EACH TABLET CONTAINS ALBENDAZOLE 400,0 mg | Not listed | 34007234/12/0072 | Cancelled | Not determined | None |
| Albendazole 400 cospharm EACH TABLET CONTAINS: ALBENDAZOLE 400,0 mg | 1 mgChewable tablet | 61084661/12/0846Approved 27 January 2026 | Registered | S2 | PIPIL |
| Nubend-400 EACH TABLET CONTAINS ALBENDAZOLE 400,0 mg | 400 | A380425A38/12/0425 | Cancelled | Not determined | None |
| Wormadole EACH TABLET CONTAINS ALBENDAZOLE 400,0 mg | 400mgTablet (chewable) | A380426A38/12/0426Approved 20 August 2025 | Registered | Not determined | PIPIL |
| Zentel suspension 20 mg/ml EACH 5 ml SUSPENSION CONTAINS ALBENDAZOLE 100 mg | 20 mg/mlSuspension | Q0075Q/12/75 | Cancelled | Not determined | None |
| Worma-worma Each Liquid Contains: 5 ml Albendazole 100 mg ; Nipastat; Sodium Saccharin; Banana Flavour BD 04434; Citric Acid Monohydrate; Polysorbate 80; Sorbitol; Tartrazine Colour Powder; Aluminum Magnesium Silicate; Sodium Carboxymethylcellulose; Glycerin; Purified Water | Not listed | U0079 | Old Medicine | Not determined | None |
Regulatory status
Where S2 sits on the scale
A pharmacist can sell it directly, without a prescription.
Schedule 2 medicines sit behind the pharmacy counter. A pharmacist can decide to sell one of these directly, using their own professional judgement, without a doctor's prescription. It can also be dispensed against a prescription like the higher tiers, in which case the usual repeat limits apply. A child under 12 may only be sold a Schedule 2 substance on a prescription, or on a written order that names the purpose and carries a signature the seller recognises. Even though it cannot be advertised to the public in the ordinary sense, its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.
Schedule S2, read from the product's PI-PIL leaflet.
The Consolidated Schedules list this ingredient up to S4; the leaflet's S2 applies to this product.
Who may supply: Only a pharmacist, pharmacist intern or supervised pharmacist's assistant may sell it without a prescription. It may otherwise be dispensed by a pharmacist against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.
Consolidated Schedules listings for Albendazole
S4: Albendazole
- except when intended for the treatment of intestinal parasites, as a single oral dose; (S2)
- except when intended and registered as an anthelmintic in terms of the provisions of the Fertilizers, Farm Feeds, Agricultural Remedies and Stock Remedies Act, 1947 (Act 36 of 1947).
Consolidated Schedules 06 July 2026, lines 5162 to 5165
S2: Albendazole
- when intended for the treatment of intestinal parasites, as a single oral dose; (S4)
- except when intended and registered as an anthelmintic in terms of the provisions of the Fertilizers, Farm Feeds, Agricultural Remedies and Stock Remedies Act, 1947 (Act 36 of 1947).
Consolidated Schedules 06 July 2026, lines 1570 to 1575
Pharmacological class: Anthelmintics, bilharzie medicines, filaricides, etc. (class 12)
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
SAHPRA documents
Schedule Verification
Zentel 400, Glaxosmithkline South Africa (Pty) Limited is scheduled S2 in its official SAHPRA documents, read with 90% confidence.
These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.